| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/04/1996 | CA2208502A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | CA2208444A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2207772A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/03/1996 | EP0719791A2 Medicaments for the treatment of restenosis and arterial sclerosis |
| 07/03/1996 | EP0719787A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| 07/03/1996 | EP0719763A1 4-(Quinolin-2-yl-methoxy)-phenyl acetic acid derivatives with antiatherosclerotic activity |
| 07/03/1996 | EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions |
| 07/03/1996 | EP0719557A1 Use of imidazopyridine derivatives for the manufacture of medicaments for the treatment of peripheral neuropathies |
| 07/03/1996 | EP0719551A2 Isolating aminoarginine and use to block nitric oxide formation in body |
| 07/03/1996 | EP0719550A2 A method of inhibiting endotoxin induced effects |
| 07/03/1996 | EP0719263A1 Heterocyclic carboxamide derivatives with antiarrhythmic activity |
| 07/03/1996 | EP0719262A1 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same |
| 07/03/1996 | EP0719252A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 07/03/1996 | EP0719156A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| 07/03/1996 | EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders |
| 07/03/1996 | EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 07/03/1996 | EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm |
| 07/03/1996 | EP0597107B1 Lignan analog, production thereof, and hypolipidemic drug |
| 07/03/1996 | CN1125946A Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/03/1996 | CN1125945A Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 07/03/1996 | CN1125941A Novel vitamin D analogues |
| 07/03/1996 | CN1125722A Ortho-substituted benzoic acid derivatives |
| 07/03/1996 | CN1125575A Adhesion receptor antagonists |
| 07/03/1996 | CN1032210C Process for preparing substituted thienopyrans as antihypertensive agents |
| 07/03/1996 | CN1032203C Process for preparing substituled 2-pyridones and pyrid-2-thiones |
| 07/02/1996 | US5532400 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents |
| 07/02/1996 | US5532387 Cyclization of trimethylhydroquinone and an alkenyl alcohol, reusable catalyst, iiib fluorosulfonate, nitrate, sulfate, or fluoroalkylsulfonate |
| 07/02/1996 | US5532368 Xanthine derivatives with adenosine-antagonistic activity |
| 07/02/1996 | US5532366 Enzyme inhibitors |
| 07/02/1996 | US5532276 Angiotensin ii antagonists, hypotensive |
| 07/02/1996 | US5532269 Administering thioctic acid or derivatives; vasodilation; side effect reduction |
| 07/02/1996 | US5532268 Increasing the serotonin, norepinephrine and dopamine in the brain using fluoxetine and alprenolol, spiperone, tetratolol and propranolol |
| 07/02/1996 | US5532264 Potentiation of venlafaxine, milnacipran and duloxetine to increase available serotonin, norepinephrine and dopamine in the brain by administering oxyalkylamine derivatives |
| 07/02/1996 | US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents |
| 07/02/1996 | US5532254 Modulation of calcium channels using benzothiophenes |
| 07/02/1996 | US5532250 Administering a serotonin 1a receptor antagonist: alprenolol, pindolol, propranolol, or tertatolol, with fluoxetine, venlafaxine, milnacipran ro duloxetine |
| 07/02/1996 | US5532244 Potentiation of drug response |
| 07/02/1996 | US5532242 Central nervous system cognition activators, anxiety and antidepressants |
| 07/02/1996 | US5532241 Cns activity |
| 07/02/1996 | US5532235 Tricyclic benzazepine vasopressin antagonists |
| 07/02/1996 | US5532233 Platelet activating factor antagonist |
| 07/02/1996 | US5532230 Administering dehydroepiandrosterone or derivatives as antiischemic agent |
| 07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
| 07/02/1996 | US5532150 Immobilized superoxide dismutase |
| 06/27/1996 | WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors |
| 06/27/1996 | WO1996019459A1 Novel sulfonamides |
| 06/27/1996 | WO1996019455A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 06/27/1996 | WO1996019451A1 Substituted azetidin-2-ones for treatment of atherosclerosis |
| 06/27/1996 | WO1996019450A1 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| 06/27/1996 | WO1996019215A1 Compositions of tocopherol and beta-carotene |
| 06/27/1996 | CA2208772A1 Low molecular weight bicyclic thrombin inhibitors |
| 06/27/1996 | CA2208530A1 Substituted azetidin-2-ones for treatment of atherosclerosis |
| 06/27/1996 | CA2208485A1 Method for protecting the heart from ischemia |
| 06/27/1996 | CA2208011A1 Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 06/26/1996 | EP0718308A2 Peptide derivatives having binding activity to modified low density lipoprotein |
| 06/26/1996 | EP0718295A1 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis |
| 06/26/1996 | EP0718294A1 2-Amino-1,3-thiazepines and their use as inhibitors of the nitrogene oxide synthase |
| 06/26/1996 | EP0718285A2 Restricted 9-cis-retinoids |
| 06/26/1996 | EP0718281A1 Cyclohexanediurea derivative and process for producing the same |
| 06/26/1996 | EP0717739A1 Bicyclic aromatic compounds as therapeutic agents |
| 06/26/1996 | EP0717733A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands |
| 06/26/1996 | EP0717625A1 A method of treating liver disease and like indications with vasodilating agents |
| 06/26/1996 | EP0717624A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
| 06/26/1996 | EP0607274B1 3-(N-ISOPROPYL-N-n-PROPYLAMINO)-5-(N-ISOPROPYL)CARBAMOYLCHROMAN |
| 06/26/1996 | EP0575361B1 New 1-aryl-4-piperazinyl-cyclohexanecarboxylic acid nitriles, their production and their use |
| 06/26/1996 | CN1125449A Sialyl Lex analogues as inhibitors of cellular adhesion |
| 06/26/1996 | CN1125444A Antiproliferative naphthyridines |
| 06/26/1996 | CN1125443A N-||1-|4(4-fluorophenoxy)butyl¨-4-piperidinyl¨-n-methylamino¨-2-benzothiazolols as class III antiarrhythmic agents |
| 06/26/1996 | CN1125442A Imidazole lipoxygenase inhibitors |
| 06/26/1996 | CN1125436A Vitamin D amide derivatives |
| 06/26/1996 | CN1125402A Potassium channel blocking compounds and their use |
| 06/26/1996 | CN1125396A Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 06/26/1996 | CN1125105A Mediodespidine |
| 06/26/1996 | CN1032136C Process for preparing dihydropyridine-3,5-dicarboxylic acid ester derivatives dextroisomer and its usage |
| 06/26/1996 | CN1032135C 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(RS) derivatives with properties of mucus-adjustment and antiischemia |
| 06/25/1996 | US5530118 Phospholipase inhibitor |
| 06/25/1996 | US5530017 Method of antagonizing angiotensin II receptors in mammals using substituted [1H-Imidazol-5-YL] alkenoic acids |
| 06/25/1996 | US5530016 Hypotensive agents |
| 06/25/1996 | US5530009 Treating asthma |
| 06/25/1996 | US5530002 Anidepressant, anxiolytic agent, hypotensive and treats disorders linked to alcoholism, sleep, phobias, obsessive compulsive behavior and migraine |
| 06/25/1996 | US5529996 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 06/25/1996 | US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE |
| 06/25/1996 | US5529992 Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors |
| 06/25/1996 | US5529790 Delayed, sustained-release diltiazem pharmaceutical preparation |
| 06/25/1996 | CA1338419C Substituted thienopyrans as antihypertensive agents |
| 06/25/1996 | CA1338417C Benzothiazepine derivatives |
| 06/20/1996 | WO1996018654A1 Factor vii fragment 82-128 and its use in blood-clotting disorders |
| 06/20/1996 | WO1996018650A1 Novel receptor |
| 06/20/1996 | WO1996018626A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 06/20/1996 | WO1996018620A1 Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient |
| 06/20/1996 | WO1996018615A1 Polyarylcarbamoylaza -and- carbamoylalkanedioic acids |
| 06/20/1996 | WO1996018602A1 Bicyclic fibrinogen antagonists |
| 06/20/1996 | WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 06/20/1996 | WO1996018395A1 Use of pramipexole as a neuroprotective agent |
| 06/20/1996 | WO1996018393A1 Novel compounds |
| 06/20/1996 | WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 06/20/1996 | WO1996004241A3 Benzoylguanidine derivatives as medicaments |
| 06/20/1996 | CA2207921A1 Novel receptor |
| 06/20/1996 | CA2207794A1 Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient |